-
What should we do about the SARS-CoV-2 virus mutants that have emerged in the UK?
Time of Update: 2021-03-06
There are many mutations (nearly 20) from the UK, eight of which occur on the prick proteins used by the virus to adsorb and infect host cells, which are the targets of new vaccines and antibody development.
-
Thermo Fly expands its Suzhou plant, a Chinese manufacturing center
Time of Update: 2021-03-06
region. One-time biotechnology container production base (hereinafter referred to as: one-time technology production base) and Suzhou Branch of China Innovation Center (hereinafter referred to as Suzhou Innovation Center), will also introduce high-end
-
Novavax New Crown Vaccine UK Phase 3 clinical trials showed 89.3% protective effectiveness
Time of Update: 2021-03-03
Today, Novavax announced that its candidate vaccine NVX-CoV2373 has reached its main endpoint in Phase 3 clinical trials in the UK, protecting the COVID-19 from symptoms by 89.3%.
-
Parkinson's UK has allocated more than 200,000 pounds for virtual biotechnology
Time of Update: 2021-03-02
announced that they would work together on a campaign and fundraiser called the Parkinson's Revolution, an indoor cycling experience that will take place in the United States, Canada and the United Kingdom on 8 February 2020 to raise awareness and raise funds for Parkinson's research and projects. （cyy123.com）
-
Neuroblastoma in the UK is seeing the development of potential new therapies
Time of Update: 2021-03-02
the treatment, which blocks N-Myc activity by shutting down gene production, is expected to conduct a clinical trial in children with high-risk neuroblastoma by the end of 2020.
-
A private equity consortium has bought LGC, the UK testing company, for 3bn pounds
Time of Update: 2021-03-01
"For more than five years, we have been actively following the development of the life sciences tool market, particularly LGC, which has been impressed by its scientific capabilities," Astorg's managing partner, Francois de Mitry, said in a statement.
-
The financial burden of cancer costs the UK an estimated 7.6 billion pounds a year
Time of Update: 2021-03-01
The study also showed that cancer affects people around patients in a similar way, with 20 percent of cancer patients currently supported by family or friends who change the way they work to take care of themselves.
-
UK cell and gene clinical trials up 45% from 2018
Time of Update: 2021-03-01
Last year's Catapult report from Cell and Gene Therapy also documented an increase in employment in the sector, showing that the industry currently supports more than 3,000 jobs, including 1,700 in manufacturing and bio-processing.
-
Pfizer UK has appointed a new managing director
Time of Update: 2021-02-26
announced the appointment of Ben Osborn as UK managing director, replacing Erik Nordkamp, who will become Pfizer's UK general manager of the pharmaceutical business and leader of the European group.
-
Parkinson's UK will inject a million pounds into drug development
Time of Update: 2021-02-26
Uk, the UK-based Parkinson's disease charity, has announced plans to invest more than a million pounds in the development of treatments to slow the progression of the disease. The charity is working with NRG Therapeutics
-
Novart moved its UK headquarters to London
Time of Update: 2021-02-26
Novart is moving its UK headquarters to London with a multi-million pound investment to be completed by January 2020. the Swiss drug giant said it was moving its UK headquarters to the WestWorks building on White City Place, a bold move
-
Despite brexit uncertainty, the UK is still looking for deals and acquisitions
Time of Update: 2021-02-26
uk's pharmaceutical industry is pushing ahead with mergers and acquisitions and can cope with any disruption caused by Brexit, according to a recent EY survey. EY's 19th Capital Confidence Barometer (CCB19), a two-yearly survey
-
The first Fusion Science Centre was launched in the UK
Time of Update: 2021-02-26
Researchers are using innovative methods that will enable the center's team to work together in new ways to accelerate scientific discovery and innovation in cancer patients and to create new treatments and technologies.
-
BMJ: Milk is the most common cause of fatal allergic reactions in children in the UK
Time of Update: 2021-02-26
, there was an increase in hospital admissions for food-related allergic reactions in the UK, but a decrease in the number of deaths. in school-age children, milk allergies are the single most common cause of fatal allergic reactions.
-
Phase III clinical trials for the treatment of COVID-19 have been approved in the UK
Time of Update: 2021-02-24
/> the main purpose of this study was to compare the advantages of Aplidin (plitidepsin) at two dose levels (1.5 or 2.5 mg) over standard care. endpoint indicator is the percentage of patients who fully recover on ± day (1).
-
The UK requires cannabidiol companies to submit new food applications within a deadline
Time of Update: 2021-02-24
